Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,20326,819,2.13 [1.72-2.65],7.914241438931361e-12
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,19690,238,3.78 [2.60-5.49],3.045524787862984e-12
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,22555,141,2.13 [1.30-3.50],0.00267638558058
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,15195,816,2.60 [2.06-3.27],4.913502577376384e-16
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22515,101,2.22 [1.24-3.95],0.0068782293259514
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,20418,90,2.76 [1.49-5.09],0.0011819460404914
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23562,100,2.12 [1.18-3.80],0.0114353626025182
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23574,68,2.20 [1.09-4.44],0.0285378366856529
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,19990,52,1.95 [0.84-4.56],0.1211818542458307
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,22559,117,2.01 [1.16-3.49],0.0133639606995169
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other septicaemia,22525,83,2.21 [1.16-4.21],0.0164604057451329
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23650,58,1.57 [0.70-3.52],0.2698490720857236
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23673,64,1.30 [0.59-2.84],0.5157295227518232
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23666,57,1.29 [0.56-2.96],0.548504209026313
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Mycoses,23327,42,1.62 [0.64-4.10],0.3085175683324438
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",22388,393,1.84 [1.36-2.51],9.216232746618256e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22150,155,2.27 [1.41-3.64],0.0007087958385219
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22261,266,1.61 [1.10-2.34],0.0131976932852353
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",18485,80,0.99 [0.48-2.04],0.9859259437220927
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18453,48,0.46 [0.19-1.13],0.0903609504757556
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",18674,269,1.25 [0.84-1.86],0.2632423570638985
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",18682,277,1.28 [0.87-1.89],0.214384381685189
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18640,235,1.22 [0.80-1.86],0.3597221205461672
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18458,53,3.88 [1.84-8.21],0.0003857584883077
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,21009,561,2.64 [2.05-3.41],8.08571953789207e-14
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",22157,379,2.13 [1.57-2.91],1.5264455908086013e-06
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23066,128,1.96 [1.15-3.33],0.012957243831743
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23718,132,1.87 [1.11-3.14],0.0181554896081966
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Rectum,23373,76,4.09 [2.22-7.53],5.901063743542147e-06
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23731,66,2.33 [1.12-4.85],0.0231541837913849
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign neoplasm: Stomach,23778,48,1.32 [0.53-3.30],0.5555880934442315
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm,23448,317,1.29 [0.91-1.84],0.157218807474386
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23740,107,1.15 [0.63-2.10],0.6575580469724266
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23750,74,1.06 [0.51-2.21],0.880191234349607
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23694,33,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,"Haemangioma, any site",23697,33,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi,23624,131,1.04 [0.59-1.82],0.9006081796961352
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,23757,55,0.77 [0.32-1.83],0.5532240926814997
PLA2G15,Phospholipase A2 group XV,Chapter II Neoplasms,Other benign neoplasms of skin,23658,137,0.69 [0.40-1.18],0.1745635324250922
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,22575,125,3.05 [1.84-5.05],1.4203980390373975e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22197,256,2.25 [1.55-3.27],1.980102179505356e-05
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22197,256,2.25 [1.55-3.27],1.980102179505356e-05
PLA2G15,Phospholipase A2 group XV,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19959,514,2.13 [1.62-2.80],5.520906225333647e-08
PLA2G15,Phospholipase A2 group XV,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23251,39,2.19 [0.87-5.54],0.0980086887902536
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23517,59,0.98 [0.43-2.20],0.9535535965257804
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18591,1442,1.61 [1.35-1.92],1.493485171060512e-07
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23052,177,1.75 [1.11-2.78],0.0168539594184003
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,20994,148,2.73 [1.67-4.45],5.943978641984581e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22403,163,2.08 [1.31-3.29],0.0018406816658935
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,20979,133,2.97 [1.78-4.95],3.181245739148628e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,21542,696,3.01 [2.37-3.83],2.530372686774016e-19
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,21517,671,2.96 [2.32-3.78],3.603435296268725e-18
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,22021,173,1.05 [0.62-1.77],0.8500833129145261
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",22021,172,1.07 [0.64-1.81],0.7909522450990015
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,18435,1286,1.50 [1.24-1.81],2.4368246873722743e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",17333,184,1.32 [0.82-2.11],0.2503083092674858
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,18332,1183,1.53 [1.26-1.86],1.606591497713654e-05
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,17200,51,1.59 [0.67-3.78],0.2981640309697811
PLA2G15,Phospholipase A2 group XV,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",17250,101,2.71 [1.51-4.84],0.0007881305287125
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Any mental disorder,20171,679,3.21 [2.54-4.06],1.4547598790949511e-22
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",19829,337,4.84 [3.53-6.64],1.7236733303786726e-22
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23211,261,4.87 [3.46-6.83],6.909125157173133e-20
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23299,199,5.55 [3.79-8.14],1.5985056476533276e-18
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,21677,79,5.59 [3.15-9.94],4.322031568476974e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",23632,79,4.31 [2.43-7.63],5.523645953349698e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",19571,79,5.82 [3.26-10.36],2.2913136634117323e-09
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Alcohol dependence,21714,116,8.04 [4.96-13.03],2.8349822755399865e-17
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Smoking dependency,21706,81,3.12 [1.67-5.82],0.0003517009245608
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19557,65,1.57 [0.72-3.41],0.2555294783711479
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",19756,264,2.66 [1.84-3.85],1.8937353532646573e-07
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression,22583,227,2.28 [1.55-3.34],2.553355932323373e-05
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Depression or dysthymia,19462,195,2.86 [1.87-4.35],1.0706097055738745e-06
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",19594,102,2.50 [1.39-4.52],0.0023588679168696
PLA2G15,Phospholipase A2 group XV,Chapter V Mental and behavioural disorders,Other anxiety disorders,22780,53,1.87 [0.83-4.20],0.1289960071550211
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Neurological diseases,20128,1320,1.51 [1.27-1.81],4.940375349215746e-06
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18118,83,2.14 [1.11-4.11],0.0229453834635988
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23677,58,2.16 [1.01-4.63],0.0481906925277135
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,22433,539,1.36 [1.03-1.78],0.0273541701484976
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Epilepsy,22060,166,2.33 [1.48-3.67],0.0002409634265013
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Migraine,21927,33,0.90 [0.30-2.76],0.8570403288216284
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23620,27,1.21 [0.37-3.99],0.7571951566960773
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Transient ischemic attack,22809,97,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other sleep disorders,22130,236,0.76 [0.50-1.15],0.1967984251614246
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Sleep apnoea,23041,186,0.69 [0.43-1.10],0.1188638850567885
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22827,472,1.09 [0.81-1.46],0.5597813180300272
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22479,124,1.32 [0.75-2.33],0.3287151973855351
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22575,220,1.17 [0.76-1.79],0.4736123652191546
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23429,89,1.65 [0.88-3.10],0.1204329089544964
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Hemiplegia,23398,58,1.40 [0.63-3.07],0.4064309562794881
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Other neurological diseases,23267,122,1.47 [0.84-2.56],0.1756530641530284
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23181,306,1.00 [0.69-1.44],0.992802931706858
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23050,175,1.25 [0.77-2.00],0.3658455573490855
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22953,78,0.84 [0.41-1.75],0.6452452535103607
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22980,105,0.94 [0.50-1.76],0.8452763549788336
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22925,50,0.82 [0.33-2.03],0.6677523298223207
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,20768,142,2.17 [1.32-3.56],0.0021651173218586
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21008,382,1.51 [1.10-2.08],0.0112559023924023
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,22806,254,1.10 [0.74-1.64],0.643557789122583
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23371,71,1.92 [0.93-3.94],0.07577275536441
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,2594,71,0.97 [0.47-2.00],0.9245967355651016
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",20848,71,2.26 [1.10-4.66],0.0265664572579767
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23115,97,1.22 [0.65-2.29],0.5332558898869771
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23070,52,1.67 [0.73-3.82],0.226116989212773
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23230,77,1.50 [0.74-3.02],0.2585031634735457
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23250,92,1.22 [0.63-2.35],0.5549656008973622
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,23683,137,1.56 [0.93-2.62],0.0953772962846024
PLA2G15,Phospholipase A2 group XV,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,22835,97,0.81 [0.42-1.53],0.5073479107382874
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16039,3759,1.72 [1.50-1.97],5.7663096374151936e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23073,59,1.99 [0.92-4.32],0.0799674962125721
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, essential",16932,2457,1.84 [1.58-2.14],7.622621183381911e-15
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertension,16977,2502,1.80 [1.55-2.10],3.3760144349807e-14
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14583,108,0.98 [0.52-1.85],0.959598067191087
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",21053,1674,1.39 [1.18-1.64],8.527299072490186e-05
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Angina pectoris,20311,932,1.45 [1.17-1.79],0.0006115940743427
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22334,332,1.70 [1.22-2.36],0.0018669274735185
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,22736,734,1.33 [1.05-1.67],0.0178904590998547
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23578,167,1.33 [0.82-2.14],0.2436919916618557
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",19883,504,1.19 [0.90-1.58],0.229992371462585
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,20786,1431,1.36 [1.14-1.62],0.0007109444366947
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Pulmonary embolism,22904,119,1.11 [0.62-1.99],0.7182130280935538
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23012,241,1.37 [0.92-2.04],0.1246254209856503
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Secondary right heart disease,22869,84,1.95 [1.02-3.74],0.0440465427831859
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22871,86,2.01 [1.06-3.82],0.0322459806716911
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14555,80,2.20 [1.09-4.42],0.0274289548725694
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18591,77,1.53 [0.76-3.08],0.2377971368249062
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Conduction disorders,18683,169,1.14 [0.70-1.86],0.5935166646620051
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,11748,135,0.78 [0.44-1.41],0.4137448204824235
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,12217,604,1.37 [1.02-1.83],0.0363251325768176
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other arrhythmias,18598,84,1.76 [0.91-3.42],0.0951857742085075
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,18640,126,1.59 [0.92-2.76],0.0950297349460404
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Heart failure, strict",22465,311,1.72 [1.21-2.44],0.0022978955885555
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",22744,184,1.52 [0.97-2.39],0.06808973094583
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",22772,166,1.63 [1.02-2.61],0.042134186350928
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",22859,147,1.57 [0.95-2.59],0.0776714131681156
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22375,88,1.11 [0.57-2.15],0.7589559132721148
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22431,144,2.02 [1.24-3.28],0.0046670256246494
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22437,151,1.65 [1.00-2.72],0.0490179664129844
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22421,135,1.75 [1.04-2.96],0.0361830189040975
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23546,128,1.58 [0.92-2.70],0.096757913967887
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Varicose veins,22624,338,0.99 [0.70-1.41],0.9619163588330276
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,Hypotension,22484,81,1.28 [0.63-2.58],0.495874315786098
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18520,2005,1.94 [1.67-2.26],2.701794827891246e-18
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23606,89,1.73 [0.91-3.27],0.0924762601960436
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Influenza and pneumonia,21648,247,2.47 [1.70-3.59],2.265657471250156e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",21610,209,2.52 [1.68-3.78],7.337330765409167e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,22792,274,1.94 [1.36-2.78],0.0002792480840745
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,22789,271,1.96 [1.37-2.81],0.0002477590150483
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22924,655,1.19 [0.93-1.52],0.1765601913336126
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic sinusitis,22342,73,0.85 [0.40-1.78],0.6624217693664225
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Nasal polyp,22437,168,0.91 [0.56-1.50],0.7250298960897599
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22694,425,1.31 [0.96-1.77],0.0874392761984231
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Deviated nasal septum,22495,226,0.91 [0.59-1.40],0.6730514091119902
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10313,60,2.51 [1.10-5.73],0.0282101997544344
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,21254,847,1.91 [1.55-2.37],2.838734497280811e-09
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Early onset COPD,22467,191,2.66 [1.74-4.08],6.945835996030039e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",22500,224,3.07 [2.09-4.52],1.2455950950173694e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",22500,224,3.07 [2.09-4.52],1.2455950950173694e-08
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",22373,660,1.36 [1.06-1.73],0.0154962790836743
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Asthma,16154,660,1.72 [1.34-2.22],2.6230868026843584e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",15807,660,1.74 [1.35-2.24],1.8320568283737705e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",16144,650,1.72 [1.34-2.22],2.7957495807391257e-05
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23349,94,2.81 [1.56-5.03],0.0005360883748695
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Interstitial lung disease,22606,74,2.68 [1.37-5.21],0.0038092946496405
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",23431,74,2.60 [1.34-5.03],0.0047049044337161
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,22599,67,2.63 [1.31-5.32],0.0068355345950558
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Pleural effusion,21447,135,2.14 [1.27-3.60],0.0043699983475021
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other diseases of pleura,21591,279,2.39 [1.67-3.43],1.91764902838357e-06
PLA2G15,Phospholipase A2 group XV,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,22398,125,2.35 [1.40-3.95],0.0012006430240079
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15815,5610,1.75 [1.57-1.96],2.775814235807269e-23
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23288,364,1.07 [0.76-1.49],0.7096023933795688
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23748,77,1.21 [0.58-2.51],0.6109239517379755
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Impacted teeth,23751,74,1.25 [0.59-2.63],0.5550768580620828
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Dental caries,23034,110,0.90 [0.49-1.64],0.7208415853624374
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23004,80,0.70 [0.34-1.42],0.3191785486016516
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23739,85,0.96 [0.48-1.95],0.919920022593474
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23003,79,1.51 [0.75-3.03],0.2463495643426617
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22771,76,0.88 [0.43-1.83],0.7398442941450756
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23681,55,0.72 [0.31-1.67],0.4392360536316975
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18193,322,2.43 [1.73-3.42],2.7677583897468786e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",19855,1984,1.94 [1.67-2.25],2.361831888782121e-18
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophagitis,18257,386,2.85 [2.09-3.88],2.8152249701008114e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,18520,649,1.80 [1.40-2.31],4.321619979978435e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,17944,73,2.62 [1.30-5.27],0.0071239663714575
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18141,270,2.51 [1.73-3.64],1.322844432112321e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Oesophageal obstruction,17944,73,3.45 [1.76-6.78],0.0003187675457905
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Gastric ulcer,18030,159,2.22 [1.37-3.61],0.0012966534052612
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Duodenal ulcer,18042,171,2.97 [1.90-4.65],1.828795225570978e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23585,116,2.47 [1.45-4.19],0.0008228593267558
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Chronic gastritis,17982,111,1.76 [0.98-3.17],0.058073722103479
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),18652,781,2.06 [1.65-2.58],2.4258287437029784e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of appendix,23619,107,1.35 [0.73-2.48],0.3344337204681085
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Functional dyspepsia,18158,287,1.38 [0.94-2.02],0.1015438801432626
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18031,160,2.00 [1.22-3.28],0.0058842381748208
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23575,169,1.88 [1.18-2.98],0.0074462440182716
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute appendicitis,23599,87,1.10 [0.55-2.17],0.7915668518291754
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Hernia,20256,2052,1.29 [1.11-1.50],0.0007365588261824
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Inguinal hernia,19341,1137,0.93 [0.76-1.13],0.4618362412805215
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Umbilical hernia,18389,185,1.45 [0.92-2.29],0.1120574203181566
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ventral hernia,18300,96,1.49 [0.79-2.81],0.2126982432595775
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,18963,759,2.10 [1.68-2.63],1.0713396039475907e-10
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22905,605,1.80 [1.40-2.31],4.201958937663854e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestines,18339,1815,1.68 [1.44-1.96],5.479507200987379e-11
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23437,56,2.66 [1.25-5.65],0.0110788083405146
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",23703,72,2.29 [1.15-4.53],0.0179006403337631
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn disease,22372,72,2.38 [1.20-4.73],0.0132953944824212
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22357,57,2.06 [0.94-4.50],0.0695527246670254
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",23646,143,1.76 [1.06-2.93],0.0287084449990934
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Ulcerative colitis,22443,143,1.83 [1.10-3.05],0.0204382501723084
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22429,129,2.24 [1.33-3.80],0.0026191220389959
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22757,457,1.82 [1.37-2.42],4.203393164299035e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22754,454,1.87 [1.41-2.49],1.783660961112178e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,16617,93,2.40 [1.30-4.45],0.0052984845039445
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal stricture,23318,93,2.16 [1.17-3.98],0.0139177495535292
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",16589,65,2.16 [1.03-4.52],0.0414494417358146
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,17063,539,1.69 [1.29-2.23],0.0001561949579902
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16612,88,1.69 [0.87-3.27],0.1182500041488544
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,16706,182,2.17 [1.40-3.38],0.0005811045460424
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Constipation,22205,166,2.15 [1.36-3.39],0.0010554209826779
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23382,53,2.50 [1.14-5.46],0.0217294634942398
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16684,160,2.02 [1.25-3.26],0.0039202914514054
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16621,97,2.02 [1.10-3.71],0.0240486951049511
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17391,867,1.38 [1.11-1.72],0.0040136663700553
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of intestine,16841,317,1.66 [1.17-2.36],0.0044864436991481
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23371,42,1.63 [0.64-4.17],0.3063446691372252
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of liver,22929,141,7.31 [4.77-11.22],7.658202172371123e-20
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of liver,22870,82,5.00 [2.74-9.13],1.5854803215904633e-07
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22609,373,2.03 [1.49-2.78],8.932154738067181e-06
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholelithiasis,22506,270,1.45 [0.99-2.12],0.0561024552916335
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Cholecystitis,22302,66,2.88 [1.42-5.85],0.0034161899153542
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22269,33,4.52 [1.82-11.22],0.0011289274734146
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis,22310,74,2.77 [1.44-5.34],0.0022683825821368
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),23575,74,2.66 [1.38-5.11],0.0033425368552621
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Diseases of the digestive system,22387,318,2.09 [1.50-2.92],1.4698853830119357e-05
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22105,36,1.31 [0.46-3.70],0.6144255998180279
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Coeliac disease,22095,26,1.11 [0.32-3.79],0.8724868245331621
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22130,61,2.66 [1.26-5.63],0.0102968918840042
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22296,227,2.02 [1.36-2.99],0.0004832932209325
PLA2G15,Phospholipase A2 group XV,Chapter XI Diseases of the digestive system,GI-bleeding,22292,223,2.03 [1.37-3.03],0.0004502455697965
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,20617,1488,1.41 [1.19-1.67],7.561704912911715e-05
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23325,92,1.60 [0.85-3.03],0.1436562787012444
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23386,452,1.20 [0.89-1.61],0.2313900797401539
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22160,459,1.49 [1.11-1.99],0.0072750200206462
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,22756,463,1.47 [1.10-1.96],0.0094584272801596
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22396,103,1.88 [1.05-3.38],0.0334649054814582
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22592,299,1.74 [1.22-2.48],0.0021227060794689
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23499,92,2.13 [1.15-3.95],0.0161049202104803
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23484,77,2.56 [1.33-4.93],0.0050757048136205
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23464,57,2.88 [1.37-6.07],0.0054316358949788
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23446,59,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23444,57,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22991,57,2.43 [1.12-5.29],0.0253641011665464
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23301,367,0.97 [0.70-1.36],0.8623443136702059
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21782,81,0.65 [0.32-1.33],0.2408867755851242
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21747,46,1.00 [0.39-2.54],0.9971375158728496
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21742,41,0.84 [0.31-2.26],0.7304501119346927
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21885,184,1.63 [1.03-2.56],0.0350067892844779
PLA2G15,Phospholipase A2 group XV,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21863,162,1.54 [0.95-2.49],0.0813969153248124
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,17542,3548,1.35 [1.20-1.53],1.524885397880891e-06
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,19025,2089,1.19 [1.03-1.39],0.0202997602939898
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,21521,1073,1.49 [1.23-1.81],5.776412113251229e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17024,88,2.99 [1.61-5.55],0.0005357265257862
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,17348,412,1.93 [1.42-2.63],2.536291843865888e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23506,85,2.81 [1.52-5.20],0.000959612912415
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23511,75,2.96 [1.55-5.65],0.0010161438703573
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17993,1057,1.10 [0.89-1.35],0.3657267037105162
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",20428,1057,1.05 [0.86-1.29],0.6266344540744906
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,17066,130,1.45 [0.83-2.54],0.1884985192749775
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",22806,126,1.57 [0.91-2.72],0.1035055339808712
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17103,167,1.66 [1.03-2.67],0.0371914463039742
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16991,55,0.90 [0.37-2.20],0.8217898053322774
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17187,251,0.63 [0.41-0.96],0.0329078449954013
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23646,120,0.60 [0.33-1.09],0.092839568259113
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17505,569,1.24 [0.94-1.64],0.1204034380814258
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,17236,300,1.28 [0.89-1.85],0.1888116393173745
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18095,1159,1.09 [0.90-1.33],0.3767301236596885
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16959,23,1.08 [0.29-4.02],0.9103154207663264
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16984,48,1.29 [0.52-3.24],0.5830566173215975
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,16966,30,0.96 [0.29-3.16],0.9525579553537464
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16951,15,0.89 [0.16-5.04],0.8973072389266982
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17532,596,0.94 [0.71-1.23],0.6526747992991628
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17456,520,0.91 [0.68-1.23],0.5472043973173013
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19186,258,1.66 [1.13-2.45],0.010486852409063
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23479,37,3.96 [1.68-9.36],0.0017108205207595
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23460,18,2.29 [0.60-8.79],0.2273929230185988
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20784,44,1.34 [0.53-3.41],0.5415721461166964
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21024,284,1.46 [1.01-2.11],0.046769643873909
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,21565,825,1.41 [1.13-1.76],0.0022882054345832
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20902,162,1.74 [1.08-2.81],0.024071799624419
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20836,96,1.00 [0.52-1.92],0.995486962828972
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21383,643,1.39 [1.08-1.78],0.0101559942924077
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20790,50,1.07 [0.44-2.62],0.8777415710153303
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20967,227,0.77 [0.50-1.18],0.227714091039747
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20839,99,1.06 [0.55-2.02],0.8695385944174877
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20807,67,1.76 [0.83-3.73],0.1372212246471433
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20858,118,1.20 [0.67-2.15],0.5336573088541035
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20792,52,2.73 [1.23-6.07],0.0138803449676076
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20996,256,2.21 [1.52-3.20],3.29882463328682e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20686,238,1.36 [0.91-2.05],0.1342847000277593
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20510,62,nan [nan-nan],
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20511,63,1.96 [0.92-4.18],0.0795206506410483
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20510,62,0.84 [0.37-1.88],0.667313253053968
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20508,60,1.24 [0.55-2.82],0.6014976862093129
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20624,176,2.15 [1.37-3.39],0.0008786235981339
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20613,165,2.08 [1.30-3.31],0.0022528200985994
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20695,247,1.13 [0.76-1.69],0.5459763219679543
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20500,52,1.46 [0.62-3.42],0.3812496048364233
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20532,84,1.43 [0.73-2.78],0.2972740458842173
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20557,109,1.25 [0.69-2.28],0.4608640641457208
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20490,42,1.68 [0.66-4.26],0.2755308813544959
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",20793,345,1.55 [1.11-2.16],0.0098992880700551
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20589,141,2.13 [1.29-3.52],0.003102205360727
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20634,186,1.27 [0.80-2.00],0.3105806519222854
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22749,104,1.69 [0.94-3.03],0.0787735350193561
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,22936,291,1.50 [1.04-2.15],0.0286258138113231
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22703,58,1.99 [0.92-4.33],0.0823243246922591
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22696,51,0.49 [0.20-1.20],0.1172700156764326
PLA2G15,Phospholipase A2 group XV,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22732,87,1.06 [0.54-2.10],0.8634217186870651
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18209,2380,1.35 [1.17-1.55],4.142914816651156e-05
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20479,1290,1.09 [0.91-1.31],0.3633406088474487
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,20959,305,1.70 [1.20-2.42],0.0030859415414264
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,20747,93,1.31 [0.68-2.51],0.4171282645471391
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Acute renal failure,20989,72,0.91 [0.43-1.92],0.8079512178596173
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,21007,90,2.03 [1.08-3.82],0.0271671645278352
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21010,93,1.81 [0.97-3.37],0.0636666939340261
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23270,359,1.41 [1.01-1.95],0.0408389579648595
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23232,79,2.06 [1.06-4.00],0.0338522172322264
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23166,255,1.37 [0.93-2.03],0.1082457180679544
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23045,134,1.23 [0.72-2.10],0.4570654873225169
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,21537,831,1.28 [1.02-1.60],0.0303405947764752
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Cystitis,20766,60,1.58 [0.71-3.51],0.2654814970798694
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20780,74,2.13 [1.06-4.27],0.0325765901036256
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21087,381,1.20 [0.87-1.67],0.2693382826759357
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Urethral stricture,20847,141,1.31 [0.77-2.23],0.3176619280691127
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,21073,367,1.42 [1.02-1.97],0.0357276381283221
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19761,572,1.01 [0.77-1.33],0.9438024646747764
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19296,107,0.63 [0.33-1.17],0.1442480707445099
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Hydrocele,19292,103,1.37 [0.75-2.52],0.307403498550946
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19354,165,1.39 [0.86-2.25],0.1793842691993294
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19350,161,0.82 [0.50-1.36],0.4440057447779151
PLA2G15,Phospholipase A2 group XV,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19407,218,1.22 [0.80-1.87],0.3555202874124753
PLA2G15,Phospholipase A2 group XV,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23257,78,1.28 [0.63-2.59],0.4886655442532996
PLA2G15,Phospholipase A2 group XV,Chapter VI Diseases of the nervous system,Falls/tendency to fall,21575,548,1.61 [1.23-2.11],0.0004906654916099
